Source: International Congress 2014 – Animal models in respiratory drug development
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
P. Nath, A. Young, V. Russell (Harlow, United Kingdom). Characterisation of a steroid-insensitive severe asthma model. Eur Respir J 2014; 44: Suppl. 58, 1781

Member's Comments

No comment yet.

Related content which might interest you: Transient receptor potential channels in a mouse model of isocyanate-induced airway hyperresponsiveness Source: International Congress 2014 – Mechanistic murine studies of asthma and lung inflammation Year: 2014 Standardization of a murine model of asthma due to soybean inhalation Source: International Congress 2015 – Occupational and environmental effects: in vitro and animal models Year: 2015 Characteristics of IL-25 and allergen-induced airways fibrosis in a murine model of asthma Source: International Congress 2015 – The immunology of allergic airway disease Year: 2015 Characteristics of the adult corticosteroid-dependent severe asthma in UBIOPRED consortium Source: International Congress 2014 – Novel targets and drugs for asthma and COPD Year: 2014 IL-13 in a mouse model of chemical-induced airway hyperresponsiveness Source: International Congress 2015 – Immune mechanisms in the human lung Year: 2015 Species comparison of interleukin-13 induced airway hyperreactivity as model for allergic asthma Source: International Congress 2014 – Animal models in respiratory drug development Year: 2014 Dose-dependent differential effects of thrombin in allergic bronchial asthma Source: Annual Congress 2013 –Murine models of lung immunology Year: 2013 Targeting IL33-ST2 pathway in virus-induced exacerbation of experimental asthma Source: International Congress 2016 – Immune responses in the lung Year: 2016 Immunomodulatory role of IL-37 in asthma pathogenesis Source: International Congress 2016 – Immune responses in the lung Year: 2016 IL33 and TSLP involvements in influenza-induced exacerbation in a murine model of chronic asthma Source: International Congress 2015 – Advances in asthma and allergy in animal models Year: 2015 Ciclesonide and tiotropium synergistically inhibit airway eosinophilia in a guinea pig model of chronic asthma Source: Annual Congress 2013 –Novel mechanisms for established drugs for asthma and COPD management Year: 2013 Adjuvant-free mouse model of allergic asthma Source: International Congress 2014 – Asthma: clinical problems Year: 2014 RIG-I receptors induced by dsRNA challenges in an HDM-mouse model of asthma exacerbation Source: International Congress 2014 – Exploring molecular mechanisms of allergy and asthma in animal models Year: 2014 Effects of LTRA on T cell-induced bronchoconstriction in the mice Source: International Congress 2015 – New models for treating airway diseases Year: 2015 Investigating the role of BAFF in murine models of allergic asthma Source: International Congress 2014 – Paediatric asthma: markers and molecules Year: 2014 Mepenzolate bromide displays beneficial effects in a mouse model of chronic obstructive pulmonary disease Source: International Congress 2014 – Animal models in respiratory drug development Year: 2014 Crucial timing of a viral component exposure to exacerbate allergen-induced asthma Source: International Congress 2016 – Clinical and molecular studies in asthma Year: 2016 The effect of different PV extracts in the treatment of asthma in an animal model Source: International Congress 2015 – Immune aspects of asthma and other airway diseases Year: 2015 ADEPT-derived, U-BIOPRED validated asthma clinical clusters with Th2 and non-Th2 phenotypes Source: International Congress 2014 – Novel targets and drugs for asthma and COPD Year: 2014 LATE-BREAKING ABSTRACT: Airway remodelling induced by ADAM33 is reversible Source: International Congress 2014 – COPD: points to ponder Year: 2014